摘要
目的:检测Smad7在脂溢性角化病、日光性角化病以及基底细胞癌中的表达。方法:对脂溢性角化病、日光性角化病及基底细胞癌标本(各30例)和30例正常标本进行免疫组化染色。结果:23例脂溢性角化病标本、23例日光性角化病标本和28例基底细胞癌标本中Smad7染色阳性,阳性细胞率分别为(31.0±23.0)%,(32.7±26.3)%和(62.6±32.1)%,均显著高于正常组织的(6.7±5.0%)。结论:Samd7可能与脂溢性角化病、日光性角化病以及基底细胞癌的发病有关。
Objective: To detect the expression of Smad7 in the lesions of seborrheic keratosis,actinic keratosis,and basal cell carcinoma. Methods: The levels of Smad7 in the lesions of seborrheic keratosis,actinic keratosis,basal cell carcinoma and normal controls( 30 lesions in each group),were detected by immunohistochemical staining. Results: Smad7 was positive in 23 seborrheic keratosis lesions,23 actinic keratosis lesions and 28 basal cell carcinoma lesions. The positivity rates of Smad7 cells were( 31.0±23.0) %,( 32.7±26.3) % and( 62.6±32.1) % respectively,which were all higher than that in the controls( 6.7±5.0) %. Conclusion: Smad7 may play a role in the pathogenesis of seborrheic keratosis,actinic keratosis and basal cell carcinoma.
作者
和义敏
章宏峰
李芃
梁小芳
姜小丽
高英
HE Yimin;ZHANG Hongfeng;LI Peng;LIANG Xiaofang;JIANG Xiaoli;GAO Ying(Department of Dermatology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, China;Department of Pathology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, China)
出处
《中国麻风皮肤病杂志》
2018年第9期524-527,共4页
China Journal of Leprosy and Skin Diseases